Product Information

PREVACID DR 30 MG SOLUTAB is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $13.2363 per EA under NDC 64764054411. Its NADAC has been published 622 times since Nov 28, 2013.

FDA first approved this application on Aug 30, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the lansoprazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PREVACID DR 30 MG SOLUTAB

lansoprazole
$13.2363per EA
High Outlier

Strength

30 mg/1

NDC

64764054411

Classification

Brand

Dosage Form

TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LANSOPRAZOLE

Approval Type

New Drug (NDA)

FDA Application

NDA021428

FDA Approved

8/30/2002

TE Code

AB

On Market Since

8/30/2002

Pharmacological Classes

Inhibition Gastric Acid Secretion
Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for PREVACID DR 30 MG SOLUTAB has been published 622 times since Nov 28, 2013, and over the history we have for it it has risen 62.1%. The table below summarizes its recorded NADAC range and movement.

Current price$13.2363 per EA
All-time high$13.5123 (Feb 15, 2017)
All-time low$8.1639 (Nov 28, 2013)
52-week high$13.2427
52-week low$13.1975
Median price$13.2352
Average price$12.5965
Largest weekly change+9.9% (Oct 14, 2015)
Weeks tracked622
Tracking sinceNov 28, 2013

Price History

1W

+0.0%

1M

+0.0%

3M

+0.1%

6M

+0.1%

1Y

+0.1%

3Y

+0.2%

5Y

+0.5%

All

+62.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 83% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 83%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of PREVACID DR 30 MG SOLUTAB?

The current National Average Drug Acquisition Cost (NADAC) for PREVACID DR 30 MG SOLUTAB, manufactured by Takeda Pharmaceuticals America, Inc., is $13.2363 per EA (NDC 64764054411), effective Aug 19, 2026.

How has the price of PREVACID DR 30 MG SOLUTAB changed over time?

Over the history we have for it, the NADAC for PREVACID DR 30 MG SOLUTAB has risen 62.1%. It has been tracked across 622 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PREVACID DR 30 MG SOLUTAB?

Since Nov 28, 2013, the NADAC for PREVACID DR 30 MG SOLUTAB has ranged from a low of $8.1639 (Nov 28, 2013) to a high of $13.5123 (Feb 15, 2017), with a median of $13.2352 per EA.

Are there cheaper alternatives to PREVACID DR 30 MG SOLUTAB?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LANSOPRAZOLE DR 30 MG ODT, is $2.2103 per EA — about 83% below PREVACID DR 30 MG SOLUTAB.

Who manufactures PREVACID DR 30 MG SOLUTAB?

PREVACID DR 30 MG SOLUTAB (NDC 64764054411) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.